Living Alone is Predictive of Non-home Discharge Following Elective Total Hip Arthroplasty: a Matched-pairs Cohort Analysis

Perioperative/Postoperative Complications Clinical Trial

Official title:

Living Alone is Predictive of Non-home Discharge Following Elective Total Hip Arthroplasty: a Matched-pairs Cohort Analysis

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06462885
• Other study ID #: HSRZOKZZ3
• Status: Completed
• Start date: January 1, 2021
• Est. completion date: January 30, 2022

Study information

• Verified date: June 2024
• Source: University of Virginia
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The goal of this observational study is to assess the effect of living alone on total hip arthroplasty thirty-day outcomes. The main questions it aims to answer are: Is living alone associated with discharge disposition (home versus non-home)? Is living alone associated with greater incidences of secondary adverse events? Participants will be sampled from the 2021 American College of Surgeons National Surgical Quality Improvement Program

Recruitment information / eligibility

• Status: Completed
• Enrollment: 5677
• Est. completion date: January 30, 2022
• Est. primary completion date: January 30, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Elective, non-emergent cases
• Living alone
• Living with others

Exclusion Criteria:

• Fracture in surgical diagnosis
• Hospital admission >1 day preoperatively
• End-stage renal disease (preoperative)
• Metastatic disease (preoperative)
• Sepsis (preoperative)
• Bleeding diathesis (preoperative)
• American Society of Anesthesiologists Physical Status Classification 5

Related Conditions & MeSH terms

• Arthropathy of Hip
• Perioperative/Postoperative Complications
• Postoperative Complications

Intervention

Behavioral:
• home support, hiving alone
Home support: living alone
• home support, living with others
Home support: living with others

Locations

Country	Name	City	State
United States	University of Virginia	Charlottesville	Virginia

Sponsors (1)

Lead Sponsor	Collaborator
University of Virginia

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Discharge disposition	Home versus non-home	Thirty days
Secondary	Requiring home services		Thirty days
Secondary	Functional status at discharge	Dependent versus independent	Thirty days
Secondary	Postoperative delirium		Thirty days
Secondary	Hospital length of stay		Thirty days
Secondary	Unplanned resource utilization	Unplanned readmission and return to the operating room	Thirty days
Secondary	Wound complications	Superficial surgical site infection (SSI), deep incisional SSI, organ space SSI, and wound dehiscence	Thirty days
Secondary	Systemic complications	Cardiac arrest, myocardial infarction, stroke, reintubation, pneumonia, deep venous thrombosis, pulmonary embolism, bleeding, sepsis, septic shock, and acute kidney injury	Thirty days
Secondary	Bleeding events	Requiring transfusion	Thirty days
Secondary	Mortality		Thirty days